| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |